Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association

Hypertension Research

Volumn 34, Issue 4, 2011, Pages 423-430

  Wang, Ji Guang ^a,k   Kario, Kazuomi ^b   Lau, Titus ^c   Wei, Yong Quek ^d   Park, Chang Gyu ^e   Kim, Cheol Ho ^f   Huang, Jun ^g   Zhang, Weizhong ^a   Li, Yong ^h   Yan, Peter ⁱ   Hu, Dayi ^j  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

^e Korea University College of Medicine   (South Korea)

^f Seoul National University Bundang Hospital   (South Korea)

^g NANJING MEDICAL UNIVERSITY   (China)

^h FUDAN UNIVERSITY   (China)

ⁱ MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^j PEKING UNIVERSITY   (China)

^k Shanghai Institute of Hypertension   (China)

more..

Author keywords

ambulatory blood pressure; calcium channel blockers; cardiovascular endpoints; randomized controlled trials; target organ damage

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; AZELNIDIPINE; BENIDIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CILNIDIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EFONIDIPINE; ENALAPRIL; FELODIPINE; ISRADIPINE; LACIDIPINE; LERCANIDIPINE; LISINOPRIL; LOSARTAN; MANIDIPINE; MEPIRODIPINE; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NISOLDIPINE; NITRENDIPINE; QUINAPRIL; TELMISARTAN; TEMOCAPRIL; UNINDEXED DRUG; VALSARTAN;

ASIAN; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED CLINICAL TRIAL (TOPIC); HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STROKE;

CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; FAR EAST; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 79953698165     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.259     Document Type: Review

References (45)

1. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823-1829. (Pubitemid 28548522)
2. Wang JG, Staessen JA, Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 2000; 160: 211-220. (Pubitemid 30054341)
3. Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Pagé V, Ghadirian P, LeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-1245. (Pubitemid 26343504)
4. Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005; 23: 2157-2172. (Pubitemid 41666745)
5. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliott P. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 2003; 17: 623-630. (Pubitemid 37265100)
6. Dwivedi G, Beevers DG. Hypertension in ethnic groups: epidemiological and clinical perspectives. Expert Rev Cardiovasc Ther 2009; 7: 955-963.
7. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315. (Pubitemid 33016494)
8. Wang JG, Li Y, Franklin S, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension 2007; 50: 181-188. (Pubitemid 46986040)
9. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108. (Pubitemid 30146610)
10. Sueda S, Kohno H, Fukuda H, Uraoka T. Did the widespread use of long-acting calcium antagonists decrease the occurrence of variant angina? Chest 2003; 124: 2074-2078. (Pubitemid 38010571)
11. Cao ZF, Duan H, Song LR. Comparison of amlodipine, fosinopril and indapamide in blood pressure lowering efficacy. Chin Hosp Pharm J 2001; 21: 297-298 (in Chinese).
12. Li L, Song Y, Cai W. Effects of amlodipine and peridopril on 24 h ambulatory blood pressure in hypertensive patients. Chin J Factory Mineral Med 2002; 15: 111-112 (in Chinese).
13. Tomlinson B, Woo J, Thomas GN, Chau YM, Critchley JA. Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult Chinese patients with hypertension. Clin Ther 2004; 26: 1292-1304. (Pubitemid 39445351)
14. Zhang DL, Li NF, Wang XL, Zhou KM. Comparison of the effects of amlodipine and enalapril in 24 h ambulatory blood pressure in elderly patients with isolated systolic hypertension. Chin J Atheroscler 2005; 13: 58-60 (in Chinese).
15. Zhang X, Wang S. The effect of nifedipine GITS tablet on ambulatory blood pressure and cerebral hemodynamics in patients with essential hypertension. Clin Med J Chin 2001; 8: 473-475 (in Chinese).
16. Zhong ZH, Liu GS, Meng FH, Li HX, Liu FY, Li XH, Zhao XM. Efficacy and T/P ratio of amlodipine and bisoprolol in essential hypertension monotherapy and effect on microcirculation. Chin J New Drugs Clin Remedy 2001; 20: 293-296 (in Chinese).
17. Eguchi K, Kario K, Shimada K. Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlo-dipine) on ventricular ectopic beats in older hypertensive patients. Hypertens Res 2002; 25: 329-333. (Pubitemid 34752550)
18. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, Ishikawa S, Shimada K. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens 2004; 17: 112-117. (Pubitemid 38125126)
19. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients. J Hum Hypertens 2006; 20: 787-794. (Pubitemid 44430678)
20. Ishimitsu T, Minami J, Yoshii M, Suzuki T, Inada H, Ohta S, Futoh Y, Ono H, Matsuoka H. Comparison of the effects of amlodipine and losartan on 24-h ambulatory blood pressure in hypertensive patients. Clin Exp Hypertens 2002; 24: 41-50. (Pubitemid 34132361)
21. Ishimitsu T, Kobayashi T, Honda T, Takahashi M, Minami J, Ohta S, Inada H, Yoshii M, Ono H, Matsuoka H. Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients. Hypertens Res 2005; 28: 351-359. (Pubitemid 40895058)
22. Chinese Hypertension Guidelines Committee. Chinese guidelines on the management of hypertension. Chin J Hypertens 2005; 13(Suppl): 2-41 (in Chinese).
23. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
24. Ikeda H, Minamikawa J, Nakamura Y, Honjo S, Hamamoto Y, Wada Y, Nabe K, Koshiyama H. Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study). Diabetes Res Clin Pract 2009; 83: 50-53.
25. Hayashi K, Kumagai H, Saruta T. Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment. Am J Hypertens 2003; 16: 116-122. (Pubitemid 36143429)
26. Ishii H, Tsukada T, Yoshida M. Angiotensin II type-I receptor blocker, candesartan, improves brachial-ankle pulse wave velocity independent of its blood pressure lowering effects in type 2 diabetes patients. Intern Med 2008; 47: 2013-2018.
27. Shinoda E, Yui Y, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C. Quantitative coronary angiogram analysis: nifedipine retard versus angioten-sin-converting enzyme inhibitors (JMIC-B side arm study). Hypertension 2005; 45: 1153-1158. (Pubitemid 40770320)
28. Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17: 1050-1055. (Pubitemid 39469329)
29. Sakata K, Yoshida H, Tamekiyo H, Obayashi K, Nawada R, Doi O, Mori N. Comparative effect of clinidipine and quinapril on left ventricular mass in mild essential hypertension. Drugs Exp Clin Res 2003; 29: 117-123. (Pubitemid 37498413)
30. Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609-614. (Pubitemid 37080793)
31. Chen W, Xu Q, Ji Y. Comparison of amlodipine and enalapril in treatment of hypertension. Chin J Hypertens 1997; 5(Suppl): 59-61 (in Chinese).
32. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54: 716-723.
33. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428.
34. ALLHAT Officers, Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
35. Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angioten-sin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension 2006; 48: 374-384. (Pubitemid 44253729)
36. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Prevention of cardiovascular events with an amlodipine-perindopril strategy compared with an atenolol-thiazide strategy. The Anglo-Scandinavian Cardiac Outcomes Trial- Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906.
37. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A. Outcomes in hypertensive patients at high cardiovascular risk treated with valsartan- or amlodi-pine-based regimens: VALUE, a randomised trial. Lancet 2004; 63: 2022-2031. (Pubitemid 38781102)
38. Hansson L, Lindholm LH, Ekbom T, Dahlöf B, Lanke J, Scherstén B, Wester PO, Hedner T, de Faire U. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751-1756.
39. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-372. (Pubitemid 30487492)
40. Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 2008; 51: 393-398. (Pubitemid 351159955)
41. National Intervention Cooperative Study in Elderly Hypertensives Study Group. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129-1133.
42. Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C. Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. Hypertens Res 2004; 27: 181-191. (Pubitemid 38489080)
43. Japanese Beta-Blockers, Calcium Antagonists Myocardial Infarction (JBCMI) Investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 2004; 93: 969-973.
44. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
45. Sasayama S. Heart disease in Asia. Circulation 2008; 118: 2669-2671.